Working… Menu

A Study of NKTR-358 (LY3471851) in Participants With Systemic Lupus Erythematosus (SLE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03556007
Recruitment Status : Completed
First Posted : June 14, 2018
Last Update Posted : July 7, 2021
Nektar Therapeutics
Information provided by (Responsible Party):
Eli Lilly and Company

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 29, 2019
Actual Study Completion Date : August 29, 2019